Diovan Related Clinical Trials
Demonstrate Non-inferiority of Combination of 5 mg Amlodipine and 80 mg Valsartan to 160 mg Valsartan [Recruiting]
Low-dose Nifedipine-Valsartan Combination Compared to Up-titrated Valsartan Monotherapy in Essential Hypertension [Recruiting]
Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease [Recruiting]
Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus [Recruiting]
A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-Term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide. [Active, not recruiting]
Valsartan Efficacy on Modest Blood Pressure Reduction in Acute Ischemic Stroke [Recruiting]
A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan. [Completed]
To Compare the Blood Level of Marketed Japanese Valsartan Tablet Formulation vs Global Valsartan Tablet Formulation in Healthy Volunteers [Completed]
Assessment of LCZ696 and Valsartan in Asian Patients With Salt-sensitive Hypertension [Recruiting]
A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy [Recruiting]
Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD [Not yet recruiting]
8-Week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension [Completed]
Bioavailability of Aliskiren and Valsartan Combined as a Single Tablet vs. the Same Medications Given Separately to Healthy Subjects. [Completed]
Bioavailability of Aliskiren and Valsartan as a Single Tablet vs. the Same Doses of the Two Drugs Given Separately to Healthy Subjects. [Completed]
Antiproteinuric Effect of Valsartan and Lisinopril [Completed]
Comparison of the Antihypertensive Efficacy of Valsartan and Enalapril After Missing One Dose [Completed]
The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome [Recruiting]
Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension [Completed]
Pharmacokinetic Study of Livalo� Fixed Combination Drug in Healthy Subjects [Not yet recruiting]
A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg [Completed]
Regression of Fatty Heart by Valsartan Therapy [Recruiting]
Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone [Completed]
Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin [Completed]
Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension [Completed]
Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in Hypertension [Completed]
Renal Protective Effects of Renin Angiotensin System (RAS) Inhibitor in Peritoneal Dialysis Patients [Recruiting]
Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension [Recruiting]
Double-dose Valsartan Monotherapy in Hypertension Treatment: an Effectiveness and Safety Evaluation in Chinese Patients. [Recruiting]
Effectiveness of Losartan 50 mg/HCTZ 12.5 mg Versus Valsartan 80 mg/HCTZ 12.5 mg Titrated as Needed in Patients With Hypertension Not Controlled on Monotherapy [Active, not recruiting]
Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia [Recruiting]
Pharmacokinetics Following Single-dose of Valsartan in Japanese Pediatric Patients [Recruiting]
Valsartan Intensified Primary Care Reduction of Blood Pressure Study [Recruiting]
Antialbuminuric Effects of Valsartan and Lisinopril [Terminated]
Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension [Completed]
A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril [Active, not recruiting]
Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone [Completed]
The Change of Urinary Angiotensinogen Excretion After Valsartan Treatment in Patients With Persistent Proteinuria [Not yet recruiting]
Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes Nephropathy [Recruiting]
The Impact of Dose of Angiotensin-receptor Blocker Valsartan and Genetic Polymorphism on the Post-MI Ventricular Remodeling [Recruiting]
FOCUS (Nifedipine GITS's Effect on Central Pressure Assessed by Applanation Tonometry) [Recruiting]
A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia [Active, not recruiting]
A Study of Valsartan Administered Once Daily Versus Twice Daily, in Patients With Stable, Chronic Heart Failure [Completed]
Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age [Recruiting]
Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide [Completed]
Preventing Microalbuminuria in Type 2 Diabetes [Recruiting]
GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence [Completed]
8 Weeks Study to Evaluate the Efficacy and Safety of Valsartan in Combination With Aliskiren Compared to Valsartan Alone in Patients With Stage 2 Hypertension [Not yet recruiting]
Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients [Completed]
Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe Hypertension [Completed]
VALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With Microalbuminuria [Completed]
VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil [Completed]
Renoprotection by Pentoxifylline and Valsartan in Chronic Kidney Disease (CKD) [Recruiting]
Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Patients With Hypertension. [Completed]
Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic Syndrome [Completed]
Valsartan Optimal Therapy Against Elevated Home Blood Pressure Research（VOYAGER）Study [Recruiting]
Efficacy and Safety of Aliskiren and Valsartan Versus Placebo in Patients Stabilized Following an Acute Coronary Syndrome [Recruiting]
Kagoshima Collaborate Trial in Metabolic Syndrome (KACT Study) [Recruiting]
A Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Phase IV Study Comparing Telmisartan 80 mg + Hydrochlorothiazide 25 mg [Micardis HCT] Versus Valsartan 160 mg + Hydrochlorothiazide 25 mg [Diovan HCT] Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension. [Completed]
Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-Moderate Hypertension. [Recruiting]
A Randomized, Double-Blind, Placebo Controlled Comparison of Telmisartan HCT and Valsartan HCT in HTN Stage I/II Patient [Completed]
Telmisartan vs. Valsartan Missed Dose [Completed]
Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril [Not yet recruiting]
Additive Effects of Pravastatin and Valsartan [Recruiting]
Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 Hypertension [Recruiting]
Long Term Safety, Tolerability and Efficacy of Valsartan and Enalapril Combined and Alone in Children With Hypertension [Recruiting]
A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia [Completed]
Pharmacokinetic Drug Interaction Study of Dapagliflozin and Valsartan or Simvastatin in Healthy Subjects [Not yet recruiting]
Comparison Of Morning And Evening Dosing Of Valsartan And Lisinopril In Patients With Diabetes [Completed]
A Study to Evaluate the Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled on Monotherapy [Completed]
To Compare the Efficacy and Safety of Tripterygium (TW) Versus Valsartan in the Diabetic Nephropathy (DN) [Recruiting]
The Use of DIOVAN to Reduce Post-Cardioversion Recurrence of Atrial Fibrillation Trial (the DRAFT Trial) [Recruiting]
Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial Dysfunction [Completed]
Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus Felodipine [Completed]
Valsartan in Cardiovascular Disease With Renal Dysfunction (The V-CARD) Study [Recruiting]
Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension [Completed]
Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy [Active, not recruiting]
Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension [Completed]
VALIDATE Valsartan and Supportive Measures - Impact on Drug Adherence of Treated Hypertensive Patients
Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease [Recruiting]
1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy [Completed]
To Compare the Efficacy and Safety of Tripterygium Wilfordii (TW) Versus Valsartan in the Membranous Nephropathy (MN) [Recruiting]
New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure Lowering [Recruiting]
Valsartan and Amlodipine Compared to Losartan and Amlodipine in Hypertensive Patients [Recruiting]
Study to Compare the Effect of Valsartan vs Atenolol on Pro-Thrombotic State in Hypertensive Patients. [Completed]
Effect of Valsartan on Carotid Artery Disease [Recruiting]
Preventing ESRD in Overt Nephropathy of Type 2 Diabetes [Recruiting]
A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension
An Efficacy and Safety Study of TAK-491 Compared to Valsartan and Olmesartan in Subjects With Essential Hypertension. [Recruiting]
Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes Mellitus
Efficacy and Safety of Valsartan Versus Placebo on Exercise Tolerance in Patients With Heart Failure
The VALIDATE Study of Valsartan for Patients With Early Stage Heart Failure [Completed]
A Study to Describe Vascular and Renal Effects and Safety of Valsartan in Patients With High Blood Pressure [Active, not recruiting]
Safety and Efficacy of Valsartan Versus Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients [Active, not recruiting]
VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women [Completed]
Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With Hypertension [No longer recruiting]
Pharmacokinetic Drug Interaction Study Following co-Administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension [Recruiting]
A Study Of Valsartan Used To Treat Hypertension For Up To 13 Months In Hypertensive Children Ages 6 - 16 Years Of Age [Completed]
A Study Of Valsartan Used To Treat Hypertension For Up To 56 Weeks In Children Ages 1 - 5 Years Who Have Hypertension [Completed]
Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria. [Completed]
Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension [Completed]
The Effects of Moderate and Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy [Recruiting]
|
